Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of NH600001 emulsion versus etomidate emulsion for sedation/anesthesia during gastroscopy or colonoscopy
ChiCTR2400084095Phase 3Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of NH600001 (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Success rate of gastroscopy and colonoscopy diagnosis/treatment. Started May 2024; status: recruiting.
02
Drugs
NH600001
Beyond the preview
Go deeper on ChiCTR2400084095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084095.